DK1032402T3 - Citicolin til behandling af motoriske neuronsygdomme og demyelinisationssygdomme - Google Patents

Citicolin til behandling af motoriske neuronsygdomme og demyelinisationssygdomme

Info

Publication number
DK1032402T3
DK1032402T3 DK98960416T DK98960416T DK1032402T3 DK 1032402 T3 DK1032402 T3 DK 1032402T3 DK 98960416 T DK98960416 T DK 98960416T DK 98960416 T DK98960416 T DK 98960416T DK 1032402 T3 DK1032402 T3 DK 1032402T3
Authority
DK
Denmark
Prior art keywords
treatment
citicolin
motor neuronal
demyelination disorders
disease
Prior art date
Application number
DK98960416T
Other languages
English (en)
Inventor
Bobby W Sandage Jr
Glenn L Cooper
Kenneth W Locke
Takashi Kiyoizumi
Original Assignee
Interneuron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interneuron Pharma filed Critical Interneuron Pharma
Application granted granted Critical
Publication of DK1032402T3 publication Critical patent/DK1032402T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fittings On The Vehicle Exterior For Carrying Loads, And Devices For Holding Or Mounting Articles (AREA)
  • Control Of Stepping Motors (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
DK98960416T 1997-11-26 1998-11-24 Citicolin til behandling af motoriske neuronsygdomme og demyelinisationssygdomme DK1032402T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6655697P 1997-11-26 1997-11-26
US6701797P 1997-12-01 1997-12-01
US12977898A 1998-08-06 1998-08-06
PCT/US1998/025051 WO1999026633A1 (en) 1997-11-26 1998-11-24 Citicoline to treat motor neuron diseases and demyelinating diseases

Publications (1)

Publication Number Publication Date
DK1032402T3 true DK1032402T3 (da) 2004-05-10

Family

ID=27370993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98960416T DK1032402T3 (da) 1997-11-26 1998-11-24 Citicolin til behandling af motoriske neuronsygdomme og demyelinisationssygdomme

Country Status (10)

Country Link
EP (1) EP1032402B1 (da)
JP (1) JP2001523724A (da)
AT (1) ATE260108T1 (da)
AU (1) AU1601499A (da)
CA (1) CA2311422A1 (da)
DE (1) DE69821970T2 (da)
DK (1) DK1032402T3 (da)
ES (1) ES2216334T3 (da)
PT (1) PT1032402E (da)
WO (1) WO1999026633A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2319020A1 (en) * 1998-02-03 1999-08-12 Senju Pharmaceutical Co., Ltd. Pharmaceutical compositions for prevention and treatment of neurodegenarative diseases
AU2003252488A1 (en) * 2002-07-11 2004-02-02 Yamasa Corporation Medicinal composition for drug-induced neuropathy
AU2018329430B2 (en) 2017-09-08 2024-05-02 Tx Medic Ab New use of dextran sulfate
US20200215149A1 (en) * 2019-01-08 2020-07-09 Christopher David Thompson N-Phenylacetyl-L-prolylglycine ethyl ester compositions and methods for using the same
RU2759654C1 (ru) * 2020-12-14 2021-11-16 Частное учреждение образовательная организация высшего образования "Медицинский университет "Реавиз" Способ интраоперационной профилактики гипоксии головного мозга во время проведения каротидной эндартерэктомии
WO2023190797A1 (ja) * 2022-03-30 2023-10-05 味の素株式会社 筋質改善用組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569929A (en) * 1980-02-29 1986-02-11 Massachusetts Institute Of Technology Cytidyl diphosphocholine-drug composition
DE3400276A1 (de) * 1984-01-05 1985-07-18 Ferrer Internacional S.A., Barcelona Verwendung von cdp-cholin zur behandlung von neurologischen stoerungen
CN1036119C (zh) * 1995-06-28 1997-10-15 北京格特生物工程科技开发公司 用于治疗视神经萎缩药物的复方制剂

Also Published As

Publication number Publication date
DE69821970D1 (de) 2004-04-01
EP1032402B1 (en) 2004-02-25
JP2001523724A (ja) 2001-11-27
ES2216334T3 (es) 2004-10-16
CA2311422A1 (en) 1999-06-03
AU1601499A (en) 1999-06-15
PT1032402E (pt) 2004-06-30
EP1032402A1 (en) 2000-09-06
WO1999026633A1 (en) 1999-06-03
ATE260108T1 (de) 2004-03-15
DE69821970T2 (de) 2004-12-16

Similar Documents

Publication Publication Date Title
BR9813524A (pt) Processos para tratamento de toxicidades associadas com a administração de um agente terapêutico a um mamìfero, para tratamento de toxicidades associadas com a exposição de um mamìfero à terapia de radiação, para tratamento de neuro- ou nefrodistúrbios em um humano, e, para tratamento de distúrbios e sintomas clìnicos associados com diabetes do tipo i ou do tipo ii em um humano
DE69533040D1 (de) Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien
KR960702318A (ko) 근육 질병 및 장애의 치료방법
ATE381935T1 (de) Verwendung von triacetyluridin zur behandlung von mitochondrialen erkrankungen
NO993393D0 (no) Fotokjemoterapeutiske blandinger
FR2721516B1 (fr) Nouvelles utilisations d'un complexe à base de phospholipides cérébraux en thérapeutique et dans l'alimentation.
WO2003092617A3 (en) Combinations for the treatment of inflammatory skin disorders
BRPI0408063A (pt) métodos e composições envolvendo mda-7
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE251888T1 (de) Rosaceae extrakt als bradykinin-antagonist
PT994743E (pt) Tratamento de disturbios inflamatorios do intestino ou da bexiga
DK1032402T3 (da) Citicolin til behandling af motoriske neuronsygdomme og demyelinisationssygdomme
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
FI973023A0 (fi) Liikakasvusairauksien yhdistetty terapeuttinen hoito
BR9912609A (pt) Métodos de uso de um análogo de somatostatina
NO20005757D0 (no) Cabergolin og pramipexol - nye anvendelser og kombinasjoner
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
NO991292L (no) Anvendelse av benzopyranoler for Õ behandle nevrologiske forstyrrelser
DK261289D0 (da) Kondenserede diazepiner, fremgangsmaader til fremstilling heraf og laegemidler indeholdende disse forbindelser
BR0111900A (pt) Uso de um antagonista do receptor do tipo 1 da angiotensina ii, formulação farmacêutica, e, métodos para o tratamento de uma condição de cefaléia vascular e para o tratamento de enxaqueca
RU93050675A (ru) Способ коррекции психофизиологического состояния человека
ES2117008T3 (es) Metodo de tratamiento con amperozida de la esquizofrenia resistente a la terapia.
DK0836853T3 (da) Anvendelse af bradykinin-antagonister til fremstilling af lægemidler til behandling og forebyggelse af Alzheimers sygdom
RU94000065A (ru) Способ лечения заболеваний позвоночника и/или суставов верхних и нижних конечностей на основе мануальной терапии
RU95117774A (ru) Способ лечения хронических воспалительных заболеваний верхних дыхательных путей